Human medicines European public assessment report (EPAR): Darunavir Viatris (previously Darunavir Mylan), darunavir, Date of authorisation: 03/01/2017, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Tobi Podhaler, tobramycin, Date of authorisation: 20/07/2011, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Afstyla, lonoctocog alfa, Date of authorisation: 04/01/2017, Revision: 12, Status: Authorised

Highlights - 20th EMA Industry Platform meeting on the operation of EU pharmacovigilance legislation meeting

Human medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 11, Status: Authorised

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - February 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 10 February 2026, 09:00 (CET) to 12 February 2026, 13:30 (CET)

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 May 2026, 14:00 (CEST) to 7 May 2026, 18:30 (CEST)

Human medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Date of authorisation: 26/07/2018, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 19, Status: Authorised

EMA welcomes political agreement on new EU pharmaceutical legislation